MannKind Corp

2026-10-16 20:02; UTC

MannKind Corp shares fell sharply, continuing a decline since Thursday, despite recent positive clinical data on Furoscix ReadyFlow's effectiveness for heart failure treatment.

2026-10-15 19:51; UTC

MannKind Corp shares are sharply higher, rebounding after seven consecutive sessions of declines.

2026-10-14 20:07; UTC

MannKind Corp shares are declining, marking seven consecutive sessions of lower closes, despite a brief rebound earlier in the session.

2026-10-13 20:08; UTC

MannKind Corp shares fell sharply, continuing a downward trend that began earlier in the week, closing well below their 20-day moving average.

2026-10-12 20:01; UTC

MannKind Corp's stock is under pressure after reports that its Furoscix ReadyFlow autoinjector showed comparable urine output to IV furosemide at the HFSA meeting.

2026-10-09 20:01; UTC

MannKind Corp shares are declining, continuing a downward trend with notable volatility, hitting a low point around mid-afternoon amid broader market weakness.

2026-10-08 20:07; UTC

MannKind Corp shares are declining, retracing from an earlier rally and closing lower compared to Wednesday's close, continuing to trade below its 20-day moving average.

2026-10-07 20:00; UTC

MannKind shares fell sharply as Truist Securities lowered its price target to $5.00 from $6.00 while maintaining a Buy rating.

2026-10-06 19:55; UTC

MannKind Corp shares fell sharply, continuing a decline since Monday's close, despite remaining above its 20-day moving average.

2026-10-05 21:01; UTC

MannKind Corp's shares declined during after-market hours on Monday, moving lower after a stable start and contrasting with recent performance above the 20-day moving average.

2026-10-02 23:05; UTC

MannKind Corp is trading modestly higher in after-market hours, reflecting typical fluctuations as it remains near the midpoint of its one-month trading range.

2026-10-01 21:01; UTC

MannKind Corp is declining in after-market trading, retracing from its opening level and hitting its lowest point shortly after the session began.

2026-09-30 23:00; UTC

MannKind Corp is trading higher in after-market hours, supported by stronger-than-expected GDP growth and a rise in private sector job additions in September.

2026-09-29 20:07; UTC

MannKind Corp's shares fell sharply, continuing a downward trend since Monday, and remain significantly below their 20-day moving average.

2026-09-28 20:41; UTC

MannKind Corp's shares declined in after-market trading, continuing a downward trend since Monday's close and remaining below its 20-day moving average.

2026-09-25 20:21; UTC

MannKind Corp's shares declined in after-market trading, significantly below its 20-day moving average and near the lower end of its one-month range.

2026-09-24 20:07; UTC

MannKind Corp's shares fell sharply, continuing a trend with five consecutive lower daily closes and remaining significantly below the 20-day moving average.

2026-09-23 23:01; UTC

MannKind Corp's shares are trading higher in after-market hours, recovering from earlier losses but remain below their 20-day moving average.

2026-09-22 23:31; UTC

MannKind Corp is experiencing a notable decline in after-market trading, shifting from a slight gain to a significant loss since Tuesday's close.

2026-09-21 23:31; UTC

MannKind Corp's shares are advancing in after-market trading, reflecting a notable rise since Monday's close, though still below the 20-day moving average.

2026-09-18 20:06; UTC

MannKind Corp's shares fell sharply after an early spike, remaining below the 20-day moving average and near the lower end of their one-month range.

2026-09-17 19:46; UTC

MannKind Corp is trading roughly flat as analysts give it an average "Moderate Buy" rating, with seven out of ten firms issuing buy recommendations.

2026-09-16 23:52; UTC

MannKind Corp is seeing higher after-market trading, reflecting broader market gains despite concerns over TIC outflows and rising Treasury yields.

2026-09-15 22:02; UTC

MannKind Corp shares are lower in after-market hours, reflecting broader market weakness and concerns from a decline in the NY Empire State Manufacturing Index.

2026-09-14 19:16; UTC

MannKind Corp shares are lower amid mixed analyst ratings and broader market declines, as inflation concerns and supply chain disruptions weigh on sentiment.

2026-09-11 19:46; UTC

MannKind Corp shares are lower today amid broader market trends and inflation data, marking a third consecutive session of declines.

2026-09-10 22:01; UTC

MannKind Corp shares are higher in after-market trading, reflecting notable gains since Thursday's close, though still below the 20-day moving average.

2026-09-09 20:01; UTC

MannKind Corp shares are lower after announcing a licensing deal with Rose Pharma for the development of ROSE-010, an inhaled GLP-1 receptor agonist.

2026-09-08 20:07; UTC

MannKind Corp's shares are higher today amid mixed analyst ratings, including a downgrade from Zacks and a price target increase from Royal Bank of Canada.

2026-09-04 19:36; UTC

MannKind Corp's shares are advancing, recovering from earlier volatility. The stock is currently above its 20-day moving average amid a stable one-month trading range.